Worth Venture Partners, LLC Brainsway Ltd. Transaction History

Worth Venture Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$3.16 - $7.07 $246,824 - $552,230	-78,109 Reduced 23.2%	258,534 $1.68 Million
Q3 2023 Nov 14, 2023	BUY	$2.24 - $4.61 $42,660 - $87,797	19,045 Added 6.0%	336,643 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$1.46 - $2.3 $463,693 - $730,475	317,598 New	317,598 $724,000
Q1 2022 May 16, 2022	SELL	$7.08 - $8.88 $330,076 - $413,994	-46,621 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.09 - $8.7 $382,711 - $469,617	-53,979 Reduced 53.66%	46,621 $359,000
Q3 2021 Nov 15, 2021	SELL	$7.4 - $10.2 $577,200 - $795,600	-78,000 Reduced 43.67%	100,600 $811,000
Q1 2021 May 17, 2021	BUY	$7.08 - $10.03 $1.26 Million - $1.79 Million	178,600 New	178,600 $1.61 Million

3.28M

Ticker BWAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,519,200
Market Cap $153M
Description
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.